These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30115763)

  • 21. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive enhancers versus addictive psychostimulants: The good and bad side of dopamine on prefrontal cortical circuits.
    Bisagno V; González B; Urbano FJ
    Pharmacol Res; 2016 Jul; 109():108-18. PubMed ID: 26826399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology.
    Volkow ND; Wang GJ; Fowler JS; Telang F
    Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3191-200. PubMed ID: 18640912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
    Schmitt KC; Reith ME
    Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine Does Double Duty in Motivating Cognitive Effort.
    Westbrook A; Braver TS
    Neuron; 2016 Feb; 89(4):695-710. PubMed ID: 26889810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.
    Bailey MR; Goldman O; Bello EP; Chohan MO; Jeong N; Winiger V; Chun E; Schipani E; Kalmbach A; Cheer JF; Balsam PD; Simpson EH
    J Neurosci; 2018 Feb; 38(9):2149-2162. PubMed ID: 29367407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine and nicotine research illustrates a range of hypocretin mechanisms in addiction.
    Baimel C; Borgland SL; Corrigall W
    Vitam Horm; 2012; 89():291-313. PubMed ID: 22640620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain mechanisms of drug reward and euphoria.
    Wise RA; Bozarth MA
    Psychiatr Med; 1985; 3(4):445-60. PubMed ID: 2893431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations in Striatal Circuits Underlying Addiction-Like Behaviors.
    Kim HJ; Lee JH; Yun K; Kim JH
    Mol Cells; 2017 Jun; 40(6):379-385. PubMed ID: 28724279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The opioid receptors as targets for drug abuse medication.
    Noble F; Lenoir M; Marie N
    Br J Pharmacol; 2015 Aug; 172(16):3964-79. PubMed ID: 25988826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of learning-related dopamine signals in addiction vulnerability.
    Huys QJ; Tobler PN; Hasler G; Flagel SB
    Prog Brain Res; 2014; 211():31-77. PubMed ID: 24968776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reflections on: "A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function".
    Nestler EJ
    Brain Res; 2016 Aug; 1645():71-4. PubMed ID: 26740398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal calcium sensor-1 deletion in the mouse decreases motivation and dopamine release in the nucleus accumbens.
    Ng E; Varaschin RK; Su P; Browne CJ; Hermainski J; Le Foll B; Pongs O; Liu F; Trudeau LE; Roder JC; Wong AH
    Behav Brain Res; 2016 Mar; 301():213-25. PubMed ID: 26738968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dopamine transporter: a crucial component regulating dopamine transmission.
    Jaber M; Jones S; Giros B; Caron MG
    Mov Disord; 1997 Sep; 12(5):629-33. PubMed ID: 9380041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurobiology of dopamine signaling.
    Girault JA; Greengard P
    Arch Neurol; 2004 May; 61(5):641-4. PubMed ID: 15148138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.